The Holy Grail In Cancer? FDA Panel Backs Blood Tests.

An FDA panel voted in favor of Grail's Galleri blood test, which screens asymptomatic patients for multiple cancers. The mixed vote represents a key step toward FDA approval for the early cancer detection technology.